Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?

Surveillance for hepatocellular carcinoma (HCC) in patients with cirrhosis is recommended in clinical guidelines. In real‐life management, surveillance rates below 20% have been reported from the United States. We aimed to determine the use of HCC‐surveillance in patients diagnosed with HCC in a European setting, and to identify the reasons for surveillance failures.

[1]  J. Marrero,et al.  Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosis , 2009, Alimentary pharmacology & therapeutics.

[2]  Xianglin L. Du,et al.  Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States , 2010, Hepatology.

[3]  H. El‐Serag,et al.  Utilization of screening for hepatocellular carcinoma in the United States. , 2008, Journal of clinical gastroenterology.

[4]  H. El‐Serag,et al.  Epidemiology of viral hepatitis and hepatocellular carcinoma. , 2012, Gastroenterology.

[5]  B. Graubard,et al.  Metabolic syndrome increases the risk of primary liver cancer in the United States: A study in the SEER‐medicare database , 2011, Hepatology.

[6]  A. Singal,et al.  Surveillance for hepatocellular carcinoma: how can we do better? , 2013, The American journal of the medical sciences.

[7]  Luci K. Leykum,et al.  Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage, treatment received, and survival. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  V. Mazzaferro,et al.  EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer , 2012 .

[9]  A. Singal,et al.  Hepatocellular carcinoma and other liver lesions. , 2014, The Medical clinics of North America.

[10]  M. Makuuchi,et al.  Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version , 2011, Digestive Diseases.

[11]  Zhao-You Tang,et al.  Randomized controlled trial of screening for hepatocellular carcinoma , 2004, Journal of Cancer Research and Clinical Oncology.

[12]  Rohit Loomba,et al.  The global NAFLD epidemic , 2013, Nature Reviews Gastroenterology &Hepatology.

[13]  J. Marrero,et al.  Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[14]  Miriam B. Vos,et al.  Increasing prevalence of nonalcoholic fatty liver disease among United States adolescents, 1988-1994 to 2007-2010. , 2013, The Journal of pediatrics.

[15]  Jasmin A. Tiro,et al.  Failure Rates in the Hepatocellular Carcinoma Surveillance Process , 2012, Cancer Prevention Research.

[16]  Jasmin A. Tiro,et al.  Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  J. Bruix,et al.  Management of hepatocellular carcinoma: An update , 2011, Hepatology.

[18]  G. Brandi,et al.  Drinking habits as cofactors of risk for alcohol induced liver damage , 1997, Gut.

[19]  K. Batts,et al.  Chronic hepatitis. An update on terminology and reporting. , 1995, The American journal of surgical pathology.

[20]  G. Hammoud,et al.  Primary hepatocellular carcinoma and metabolic syndrome: An update. , 2013, World journal of gastrointestinal oncology.

[21]  P. Newsome,et al.  Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis , 2010, Alimentary pharmacology & therapeutics.

[22]  Peter J. Richardson,et al.  Hepatocellular Carcinoma Screening Practices in the Department of Veterans Affairs: Findings from a National Facility Survey , 2013, Digestive Diseases and Sciences.

[23]  William M. Lee,et al.  Utilization of Hepatocellular Carcinoma Surveillance Among American Patients: A Systematic Review , 2012, Journal of General Internal Medicine.

[24]  B. Sangro,et al.  O110 AN INTERNATIONAL COLLABORATIVE STUDY ASSESSING THE ROLE OF AETIOLOGY AND STAGE IN SURVIVAL IN HCC – IMPLICATIONS FOR SCREENING , 2014 .

[25]  Jasmin A. Tiro,et al.  Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening. , 2013, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[26]  Amit G. Singal,et al.  Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis , 2014, PLoS medicine.

[27]  Steve S. Choi,et al.  Risk for Hepatocellular Carcinoma in Patients With Alcoholic Cirrhosis , 2012, Annals of Internal Medicine.

[28]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[29]  Rocio Lopez,et al.  The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis , 2010, Hepatology.

[30]  J. Bruix,et al.  Management of HCC. , 2012, Journal of hepatology.